State Street SPDR S&P Biotech ETF (XBI)

State Street SPDR S&P Biotech ETF is trading at $152.78, down 0.30% on the session. The 50 day average sits at $157.96 and the 200 day at $140.16, which puts the stock in a uptrend. RSI is at 35.9, which reads as weak, and MACD is bearish crossover. Volume is above average.

The nearest support is around $143.78 with resistance near $159.98, so that band frames the current range. Average daily movement is roughly $4.40, or about 2.9% of the share price, which is what any stop placement has to allow for. The overall health score of 52 out of 100 combines a trend score of 57, momentum of 25 and a risk score of 83.

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").